Stage IVB Lung Cancer AJCC v8 Recruiting Phase 1 Trials for Pembrolizumab (DB09037)

IndicationStatusPhase
DBCOND0111251 (Stage IVB Lung Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02595866Pembrolizumab in Treating Patients With HIV and Relapsed, Refractory, or Disseminated Malignant NeoplasmsTreatment
NCT03590054A Phase 1b Dose Escalation/Expansion Study of Abexinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumor MalignanciesTreatment
NCT04007744Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid TumorsTreatment